Events in the eurozone have quickly moved from threats to market shock. Wharton’s Mauro Guillen discusses what is likely to unfold. “There is no other way to describe the situation except as chaotic. This is almost like ‘The Twilight Zone.’”
Events in the eurozone have quickly moved from threats to market shock. Wharton’s Mauro Guillen discusses what is likely to unfold. “There is no other way to describe the situation except as chaotic. This is almost like ‘The Twilight Zone.’”
If we were rational, we would make choices based on long-term goals, not short-term desires. But that’s not always the case. New research by Wharton’s Howard Kunreuther suggests ways to change our decision-making processes for the better.
A year after the Supreme Court’s Hobby Lobby decision, a big question remains: How far do corporate religious rights go? Wharton’s Amy Sepinwall offers some answers in two recent papers.
The Supreme Court ruling on health care subsidies has averted disruption of the market, but more states may tap the federal marketplace, say experts.
A new e-book co-authored by Wharton professor Kevin Werbach offers ideas for using game elements to engage customers, employees and others.
Are the FDA’s medical device regulations too hard, too soft, or just right? Wharton research indicates that the agency is on the right track.
Wharton finance professor Philipp Illeditsch and colleagues have created a model that captures a valuable new way to value bonds, based on volatility and risk premiums.
Bragging about generous deeds could bring individuals praise or scorn, depending on their motivations, says Wharton’s Deborah Small.
Research by Wharton’s Vincent Buccola focuses on the question of whose rights should take precedence in the case of a municipal bankruptcy.
The new health care landscape is fueling consolidation for hospitals, physicians groups — and now insurers. So who are the winners and losers?
The Joseph H. Lauder Institute
256 South 37th street
2nd Floor
Philadelphia, PA 19104-6330